18 June 2014
HCP signs deal to sell assets of NYX Cosmetics to L’Oréal
US-focused private equity firm HCP & Company has signed an agreement to sell its investment in NYX Cosmetics to cosmetics manufacturer L'Oréal.
Focus:
-
17 June 2014
DermWORX, LETI launch new dermatological products in US
DermWORX Professional Skincare has partnered with the biopharmaceutical company LETI Laboratories to launch a series of dermatological products in the US.
-
16 June 2014
Logos Technologies introduce biodegradable surfactants for multiple insdustries
Logos Technologies is set to introduce a range of completely biodegradable surfactants, the NatSurFact surfactants, for use in personal care and household cleaning products.
-
12 June 2014
Celluence launches new anti-cellulite cream
Celluence creams has launched a new anti-cellulite cream, the Celluence Phase One, which is designed to work against the cellulite in the body.
-
11 June 2014
Helen of Troy buys VMS supplier Healthy Directions for $195m
Personal care consumer products Helen of Troy has signed an agreement to acquire US-based vitamins, minerals and supplements (VMS) supplier Healthy Directions along with its subsidiaries for about $195m.
-
10 June 2014
American Laser Skincare introduces Envy Medical products in US
US-based skincare solutions provider American Laser Skincare has launched a new range of Envy Medical products to its Philadelphia, Boston, Detroit and Dallas area clinics.
-
9 June 2014
Elyptol launches hand sanitization products in US
Australia based consumer goods company Elyptol has launched its hand hygiene and sanitization products across the US.
-
2 June 2014
Power Shark Capital secures exclusive distribution rights for Beautyject products
Power Shark Capital (PSC), a business development company, has secured exclusive rights for sales and distribution of beauty care and cosmetic company Beautyject.
-
29 May 2014
Malina Joy Skincare introduces TriplePower Vitamin C Serum
Malina Joy Skincare has launched the new TriplePower C 20% Vitamin C serum through Amazon.com.
-
27 May 2014
Nestle to acquire skin care treatment rights from Valeant
US-based pharmaceutical firm Valeant Pharmaceuticals International has signed a deal with the Swiss food group Nestle to sell rights to various skin care treatments for $1.4bn.